查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1307832

高內涵篩選的全球市場 - 產業趨勢和2030年為止的預測

Global High Content Screening Market - Industry Trends and Forecast to 2030
出版日期: | 出版商: Data Bridge Market Research | 英文 551 Pages | 商品交期: 請詢問到貨日

價格

全球高內涵篩選的市場規模在2022年估算為24億5,020萬美金。該市場在2023年～2030年關於7.3％的年複合成長率擴大，到2030年達到之前達到43億525萬9,280美元。

本報告提供全球高內涵篩選市場相關調查，提供市場概要，以及各產品類型，各用途，各技術，各終端用戶，各流通管道，各地區的趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 簡介

第2章 市場區隔

第3章 摘要整理

第4章 重要考察

  • PESTEL分析
  • 波特的五力分析

第5章 全球高內涵篩選市場:法規

第6章 市場概要，全球高內涵篩選市場

  • 促進因素
  • 阻礙因素
  • 機會
  • 課題

第7章 全球高內涵篩選市場，各產品類型

  • 概要
  • 設備
  • 軟體
  • 消耗品
  • 飾品
  • 服務

第8章 全球高內涵篩選市場，各用途

  • 概要
  • 一次·二次篩檢
  • 標的鑑定和驗證
  • 毒性研究
  • 化合物分析
  • 其他

第9章 全球高內涵篩選市場，各技術

  • 概要
  • 顯微鏡檢驗
  • 流式細胞技術
  • 免疫組織化學
  • 質譜分析法
  • ELISA
  • 西方印漬術
  • 其他

第10章 全球高內涵篩選市場，各終端用戶

  • 概要
  • 製藥公司及生物科技企業
  • CRO
  • 研究室
  • 學術機構及政府機關
  • 其他

第11章 全球高內涵篩選市場，各流通管道

  • 概要
  • 直接競標
  • 零售

第12章 全球高內涵篩選市場，各地區

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第13章 全球高內涵篩選市場，企業形勢

第14章 全球高內涵篩選市場，企業簡介

  • THERMO FISHER SCIENTIFIC INC
  • BD
  • PERKINELMER INC
  • YOKOGAWA ELECTRIC CORPORATION
  • MOLECULAR DEVICES, LLC
  • AGILENT TECHNOLOGIES, INC
  • ALIGNED GENETICS, INC
  • ARACELI BIOSCIENCES
  • AXXAM S.P.A
  • BIO-RAD LABORATORIES, INC
  • CARL ZEISS AG
  • CORNING INCORPORATED
  • DE NOVO SOFTWARE

The global high content screening market is expected to reach USD 4,305,259.28 thousand by 2030 from USD 2,450,200.00 thousand in 2022, growing at a CAGR of 7.3% during the forecast period of 2023 to 2030.

Market Segmentation

Global High Content Screening Market, By Product Type (Instruments, Consumables, Software, Services, and Accessories), Application (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling, and Others), Technology (Microscopy, Flow Cytometry, Mass Spectrometry, Western Blotting, ELISA, Immunohistochemistry, and Others), End User (Pharmaceutical and Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations, Laboratories, and Others), Distribution Channel (Direct Tenders and Retail Sales), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Denmark, Netherlands, Switzerland, Sweden, Poland, Norway, Finland, Rest of Europe, Japan, China, India, South Korea, Australia, New Zealand, Singapore, Thailand, Malaysia, Vietnam, Taiwan, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, Bahrain, U.A.E., Kuwait, Oman, Qatar, Egypt, Israel, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2030.

Overview of Global High Content Screening Market Dynamics

  • Driver
  • Increasing drug discovery and development activities
  • Restraint
  • High cost associated with initial setup and maintenance
  • Opportunity
  • The growing number of Contract Research Organizations (CROs) providing HCS services

Market Players

Some of the major market players operating in the global high content screening market are:

  • BD
  • Merck KGaA
  • Corning Incorporated
  • Carl Zeiss AG
  • Sartorius AG
  • EVIDENT
  • Zifo RnD Solutions
  • Axxam S.p.A.
  • Molecular Devices, LLC. (Subsidiary of Danaher Corporation)
  • Thermo Fisher Scientific Inc.
  • PerkinElmer Inc.
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Yokogawa Electric Corporation
  • Sysmex Corporation
  • Genedata AG
  • De Novo Software
  • Araceli Biosciences
  • Miltenyi Biotec
  • Aligned Genetics, Inc.

TABLE OF CONTENTS

1 INTRODUCTION 60

  • 1.1 OBJECTIVES OF THE STUDY 60
  • 1.2 MARKET DEFINITION 60
  • 1.3 OVERVIEW OF THE GLOBAL HIGH CONTENT SCREENING MARKET 60
  • 1.4 LIMITATIONS 62
  • 1.5 MARKETS COVERED 62

2 MARKET SEGMENTATION 66

  • 2.1 MARKETS COVERED 66
  • 2.2 GEOGRAPHICAL SCOPE 67
  • 2.3 YEARS CONSIDERED FOR THE STUDY 68
  • 2.4 CURRENCY AND PRICING 68
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 69
  • 2.6 MULTIVARIATE MODELLING 72
  • 2.7 PRODUCT TYPE LIFELINE CURVE 72
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 73
  • 2.9 DBMR MARKET POSITION GRID 74
  • 2.10 MARKET APPLICATION COVERAGE GRID 75
  • 2.11 VENDOR SHARE ANALYSIS 76
  • 2.12 SECONDARY SOURCES 77
  • 2.13 ASSUMPTIONS 77

3 EXECUTIVE SUMMARY 78

4 PREMIUM INSIGHTS 80

  • 4.1 PESTEL ANALYSIS 83
  • 4.2 PORTER'S FIVE FORCES MODEL 84

5 GLOBAL HIGH CONTENT SCREENING MARKET: REGULATIONS 85

6 MARKET OVERVIEW, GLOBAL HIGH CONTENT SCREENING MARKET 87

  • 6.1 DRIVERS 89
    • 6.1.1 ADVANCEMENT IN IMAGING TECHNOLOGIES USED FOR HIGH CONTENT SCREENING 89
    • 6.1.2 STRATEGIC INITIATIVES TAKEN BY MARKET PLAYERS 89
    • 6.1.3 INCREASING RESEARCH ACTIVITIES ASSOCIATED WITH THE USAGE OF HIGH CONTENT SCREENING 90
    • 6.1.4 INCREASING DRUG DISCOVERY AND DEVELOPMENT ACTIVITIES 91
  • 6.2 RESTRAINTS 91
    • 6.2.1 HIGH COST ASSOCIATED WITH INITIAL SETUP AND MAINTENANCE 91
    • 6.2.2 COMPLEXITY ASSOCIATED WITH CELLULAR AND MOLECULAR SAMPLES 92
  • 6.3 OPPORTUNITIES 93
    • 6.3.1 GROWING NUMBER OF CONTRACT RESEARCH ORGANIZATIONS (CROS) PROVIDING HCS SERVICES 93
    • 6.3.2 RISING INTEGRATION WITH ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN DRUG DISCOVERY AND DEVELOPMENT 93
    • 6.3.3 INCREASING GOVERNMENT INITIATIVE AND FUNDING IN R&D 94
  • 6.4 CHALLENGES 94
    • 6.4.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS TO OPERATE HCS 94
    • 6.4.2 DATA SECURITY AND DATA MANAGEMENT PROBLEMS IN HCS 95

7 GLOBAL HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE 96

  • 7.1 OVERVIEW 97
  • 7.2 INSTRUMENTS 100
    • 7.2.1 CELL IMAGING AND ANALYSIS SYSTEM 101
      • 7.2.1.1 FIXED 101
      • 7.2.1.2 MOBILE 101
    • 7.2.2 HIGH-CONTENT AND SCREENING SYSTEM 101
      • 7.2.2.1 FIXED 102
      • 7.2.2.2 MOBILE 102
    • 7.2.3 FLOW CYTOMETRY 102
    • 7.2.4 INVITROGEN HCA ONSTAGE INCUBATOR 102
    • 7.2.5 MICROPLATE MOVER 102
    • 7.2.6 OTHERS 102
  • 7.3 SOFTWARE 102
  • 7.4 CONSUMABLES 103
    • 7.4.1 REAGENTS & ASSAY KITS 104
    • 7.4.2 MICROPLATES 104
    • 7.4.3 OTHERS 104
  • 7.5 ACCESSORIES 104
  • 7.6 SERVICES 105

8 GLOBAL HIGH CONTENT SCREENING MARKET, BY APPLICATION 107

  • 8.1 OVERVIEW 108
  • 8.2 PRIMARY AND SECONDARY SCREENING 111
    • 8.2.1 INSTRUMENTS 112
    • 8.2.2 CONSUMABLES 112
    • 8.2.3 ACCESSORIES 112
    • 8.2.4 SERVICES 112
  • 8.3 TARGET IDENTIFICATION AND VALIDATION 112
    • 8.3.1 INSTRUMENTS 113
    • 8.3.2 CONSUMABLES 113
    • 8.3.3 ACCESSORIES 113
    • 8.3.4 SERVICES 114
  • 8.4 TOXICITY STUDIES 114
    • 8.4.1 INSTRUMENTS 115
    • 8.4.2 CONSUMABLES 115
    • 8.4.3 ACCESSORIES 115
    • 8.4.4 SERVICES 115
  • 8.5 COMPOUND PROFILING 115
    • 8.5.1 INSTRUMENTS 116
    • 8.5.2 CONSUMABLES 116
    • 8.5.3 ACCESSORIES 116
    • 8.5.4 SERVICES 117
  • 8.6 OTHER APPLICATIONS 117

9 GLOBAL HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY 118

  • 9.1 OVERVIEW 119
  • 9.2 MICROSCOPY 122
  • 9.3 FLOW CYTOMETRY 122
  • 9.4 IMMUNOHISTOCHEMISTRY 123
  • 9.5 MASS SPECTROMETRY 124
  • 9.6 ELISA 125
  • 9.7 WESTERN BLOTTING 126
  • 9.8 OTHERS 126
    • 9.8.1 3D CELL CULTURE MODEL 127
      • 9.8.1.1 STEROIDS 128
      • 9.8.1.2 ORGANOIDS 128
      • 9.8.1.3 TISSUE ON A CHIP 128
    • 9.8.2 EXTRACELLULAR MATRIX BASED SCAFFOLD 128
    • 9.8.3 SYNTHETIC HYDROGEL AND SCAFFOLD 128

10 GLOBAL HIGH CONTENT SCREENING MARKET, BY END USER 129

  • 10.1 OVERVIEW 130
  • 10.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 133
    • 10.2.1 INSTRUMENTS 133
    • 10.2.2 CONSUMABLES 134
    • 10.2.3 ACCESSORIES 134
    • 10.2.4 SERVICES 134
  • 10.3 CONTRACT RESEARCH ORGANIZATIONS 134
    • 10.3.1 INSTRUMENTS 135
    • 10.3.2 CONSUMABLES 135
    • 10.3.3 ACCESSORIES 135
    • 10.3.4 SERVICES 135
  • 10.4 LABORATORIES 136
    • 10.4.1 INSTRUMENTS 137
    • 10.4.2 CONSUMABLES 137
    • 10.4.3 ACCESSORIES 137
    • 10.4.4 SERVICES 137
  • 10.5 ACADEMIC AND GOVERNMENT INSTITUTES 137
    • 10.5.1 INSTRUMENTS 138
    • 10.5.2 CONSUMABLES 138
    • 10.5.3 ACCESSORIES 138
    • 10.5.4 SERVICES 138
  • 10.6 OTHERS 139

11 GLOBAL HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL 140

  • 11.1 OVERVIEW 141
  • 11.2 DIRECT TENDERS 144
  • 11.3 RETAIL SALES 144

12 GLOBAL HIGH CONTENT SCREENING MARKET, BY REGION 146

  • 12.1 OVERVIEW 147
  • 12.2 NORTH AMERICA 152
    • 12.2.1 U.S. 163
    • 12.2.2 CANADA 170
    • 12.2.3 MEXICO 177
  • 12.3 EUROPE 184
    • 12.3.1 GERMANY 196
    • 12.3.2 FRANCE 203
    • 12.3.3 U.K. 210
    • 12.3.4 ITALY 217
    • 12.3.5 SPAIN 224
    • 12.3.6 RUSSIA 231
    • 12.3.7 TURKEY 238
    • 12.3.8 BELGIUM 245
    • 12.3.9 DENMARK 252
    • 12.3.10 NETHERLANDS 259
    • 12.3.11 SWITZERLAND 266
    • 12.3.12 SWEDEN 273
    • 12.3.13 POLAND 280
    • 12.3.14 NORWAY 287
    • 12.3.15 FINLAND 294
    • 12.3.16 REST OF EUROPE 301
  • 12.4 ASIA-PACIFIC 302
    • 12.4.1 JAPAN 314
    • 12.4.2 CHINA 321
    • 12.4.3 INDIA 328
    • 12.4.4 SOUTH KOREA 335
    • 12.4.5 AUSTRALIA 342
    • 12.4.6 NEW ZEALAND 349
    • 12.4.7 SINGAPORE 356
    • 12.4.8 THAILAND 363
    • 12.4.9 MALAYSIA 370
    • 12.4.10 VIETNAM 377
    • 12.4.11 TAIWAN 384
    • 12.4.12 INDONESIA 391
    • 12.4.13 PHILIPPINES 398
    • 12.4.14 REST OF ASIA-PACIFIC 405
  • 12.5 SOUTH AMERICA 406
    • 12.5.1 BRAZIL 417
    • 12.5.2 ARGENTINA 424
    • 12.5.3 REST OF SOUTH AMERICA 431
  • 12.6 MIDDLE EAST AND AFRICA 432
    • 12.6.1 SOUTH AFRICA 443
    • 12.6.2 SAUDI ARABIA 450
    • 12.6.3 BAHRAIN 457
    • 12.6.4 U.A.E 464
    • 12.6.5 KUWAIT 471
    • 12.6.6 OMAN 478
    • 12.6.7 QATAR 485
    • 12.6.8 EGYPT 492
    • 12.6.9 ISRAEL 499
    • 12.6.10 REST OF MIDDLE EAST AND AFRICA 506

13 GLOBAL HIGH CONTENT SCREENING MARKET, COMPANY LANDSCAPE 507

  • 13.1 COMPANY SHARE ANALYSIS: GLOBAL 507
  • 13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 508
  • 13.3 COMPANY SHARE ANALYSIS: EUROPE 509
  • 13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 510

14 GLOBAL CONTENT SCREENING MARKET, COMPANY PROFILES 511

  • 14.1 THERMO FISHER SCIENTIFIC INC. (2022) 511
    • 14.1.1 COMPANY SNAPSHOT 511
    • 14.1.2 REVENUE ANALYSIS 511
    • 14.1.3 COMPANY SHARE ANALYSIS 512
    • 14.1.4 PRODUCT PORTFOLIO 512
    • 14.1.5 RECENT DEVELOPMENT 512
  • 14.2 BD 513
    • 14.2.1 COMPANY SNAPSHOT 513
    • 14.2.2 REVENUE ANALYSIS 513
    • 14.2.3 COMPANY SHARE ANALYSIS 514
    • 14.2.4 PRODUCT PORTFOLIO 514
    • 14.2.5 RECENT DEVELOPMENTS 514
  • 14.3 PERKINELMER INC. (2022) 515
    • 14.3.1 COMPANY SNAPSHOT 515
    • 14.3.2 REVENUE ANALYSIS 515
    • 14.3.3 COMPANY SHARE ANALYSIS 516
    • 14.3.4 PRODUCT PORTFOLIO 516
    • 14.3.5 RECENT DEVELOPMENTS 517
  • 14.4 YOKOGAWA ELECTRIC CORPORATION (2022) 518
    • 14.4.1 COMPANY SNAPSHOT 518
    • 14.4.2 REVENUE ANALYSIS 518
    • 14.4.3 COMPANY SHARE ANALYSIS 519
    • 14.4.4 PRODUCT PORTFOLIO 519
    • 14.4.5 RECENT DEVELOPMENT 519
  • 14.5 MOLECULAR DEVICES, LLC. (A SUBSIDIARY OF DANAHER CORPORATION) 520
    • 14.5.1 COMPANY SNAPSHOT 520
    • 14.5.2 REVENUE ANALYSIS 520
    • 14.5.3 COMPANY SHARE ANALYSIS 521
    • 14.5.4 PRODUCT PORTFOLIO 521
    • 14.5.5 RECENT DEVELOPMENT 522
  • 14.6 AGILENT TECHNOLOGIES, INC. (2022) 523
    • 14.6.1 COMPANY SNAPSHOT 523
    • 14.6.2 REVENUE ANALYSIS 523
    • 14.6.3 PRODUCT PORTFOLIO 524
    • 14.6.4 RECENT DEVELOPMENT 524
  • 14.7 ALIGNED GENETICS, INC. (2022) 525
    • 14.7.1 COMPANY SNAPSHOT 525
    • 14.7.2 REVENUE ANALYSIS 525
    • 14.7.3 PRODUCT PORTFOLIO 526
    • 14.7.4 RECENT DEVELOPMENT 526
  • 14.8 ARACELI BIOSCIENCES 527
    • 14.8.1 COMPANY SNAPSHOT 527
    • 14.8.2 PRODUCT PORTFOLIO 527
    • 14.8.3 RECENT DEVELOPMENT 527
  • 14.9 AXXAM S.P.A 528
    • 14.9.1 COMPANY SNAPSHOT 528
    • 14.9.2 PRODUCT PORTFOLIO 528
    • 14.9.3 RECENT DEVELOPMENT 528
  • 14.10 BIO-RAD LABORATORIES, INC. (2022) 529
    • 14.10.1 COMPANY SNAPSHOT 529
    • 14.10.2 REVENUE ANALYSIS 529
    • 14.10.3 PRODUCT PORTFOLIO 530
    • 14.10.4 RECENT DEVELOPMENTS 530
  • 14.11 CARL ZEISS AG 531
    • 14.11.1 COMPANY SNAPSHOT 531
    • 14.11.2 REVENUE ANALYSIS 531
    • 14.11.3 PRODUCT PORTFOLIO 532
    • 14.11.4 RECENT DEVELOPMENT 532
  • 14.12 CORNING INCORPORATED 533
    • 14.12.1 COMPANY SNAPSHOT 533
    • 14.12.2 REVENUE ANALYSIS 533
    • 14.12.3 PRODUCT PORTFOLIO 534
    • 14.12.4 RECENT DEVELOPMENT 534
  • 14.13 DE NOVO SOFTWARE 535
    • 14.13.1 COMPANY SNAPSHOT 535
    • 14.13.2 PRODUCT PORTFOLIO 535
    • 14.13.3 RECENT DEVELOPMENTS 535
  • 14.14 EVIDENT 536
    • 14.14.1 COMPANY SNAPSHOT 536
    • 14.14.2 PRODUCT PORTFOLIO 536
    • 14.14.3 RECENT DEVELOPMENT 536
  • 14.15 GENEDATA AG 537
    • 14.15.1 COMPANY SNAPSHOT 537
    • 14.15.2 PRODUCT PORTFOLIO 537
    • 14.15.3 RECENT DEVELOPMENT 537
  • 14.16 MERCK KGAA 538
    • 14.16.1 COMPANY SNAPSHOT 538
    • 14.16.2 REVENUE ANALYSIS 538
    • 14.16.3 PRODUCT PORTFOLIO 539
    • 14.16.4 RECENT DEVELOPMENTS 539
  • 14.17 MILTENYI BIOTEC 540
    • 14.17.1 COMPANY SNAPSHOT 540
    • 14.17.2 PRODUCT PORTFOLIO 540
    • 14.17.3 RECENT DEVELOPMENT 541
  • 14.18 SARTORIUS AG 542
    • 14.18.1 COMPANY SNAPSHOT 542
    • 14.18.2 REVENUE ANALYSIS 542
    • 14.18.3 PRODUCT PORTFOLIO 543
    • 14.18.4 RECENT DEVELOPMENTS 543
  • 14.19 SYSMEX CORPORATION 544
    • 14.19.1 COMPANY SNAPSHOT 544
    • 14.19.2 REVENUE ANALYSIS 544
    • 14.19.3 PRODUCT PORTFOLIO 545
    • 14.19.4 RECENT DEVELOPMENT 545
  • 14.20 ZIFO RND SOLUTIONS 546
    • 14.20.1 COMPANY SNAPSHOT 546
    • 14.20.2 PRODUCT PORTFOLIO 546
    • 14.20.3 RECENT DEVELOPMENTS 546

15 QUESTIONNAIRE 547

16 RELATED REPORTS 551

LIST OF TABLES

  • TABLE 1 GLOBAL HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 99
  • TABLE 2 GLOBAL INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 100
  • TABLE 3 GLOBAL INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 101
  • TABLE 4 GLOBAL CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 101
  • TABLE 5 GLOBAL HIGH-CONTENT AND SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 102
  • TABLE 6 GLOBAL SOFTWARES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 103
  • TABLE 7 GLOBAL CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 104
  • TABLE 8 GLOBAL CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 104
  • TABLE 9 GLOBAL ACCESSORIES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 105
  • TABLE 10 GLOBAL SERVICES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 106
  • TABLE 11 GLOBAL HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 110
  • TABLE 12 GLOBAL PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 111
  • TABLE 13 GLOBAL PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 112
  • TABLE 14 GLOBAL TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 113
  • TABLE 15 GLOBAL TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 113
  • TABLE 16 GLOBAL TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 114
  • TABLE 17 GLOBAL TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 115
  • TABLE 18 GLOBAL COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 116
  • TABLE 19 GLOBAL COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 116
  • TABLE 20 GLOBAL OTHER APPLICATION IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 117
  • TABLE 21 GLOBAL HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 121
  • TABLE 22 GLOBAL MICROSCOPY IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 122
  • TABLE 23 GLOBAL FLOW CYTOMETRY IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 123
  • TABLE 24 GLOBAL IMMUNOHISTOCHEMISTRY IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 124
  • TABLE 25 GLOBAL MASS SPECTROSCOPY IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 125
  • TABLE 26 GLOBAL ELISA IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 125
  • TABLE 27 GLOBAL WESTERN BLOTTING IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 126
  • TABLE 28 GLOBAL OTHERS IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 127
  • TABLE 29 GLOBAL OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 127
  • TABLE 30 GLOBAL 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 128
  • TABLE 31 GLOBAL HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 132
  • TABLE 32 GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 133
  • TABLE 33 GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 133
  • TABLE 34 GLOBAL CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 135
  • TABLE 35 GLOBAL CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 135
  • TABLE 36 GLOBAL LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 136
  • TABLE 37 GLOBAL LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 136
  • TABLE 38 GLOBAL ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 138
  • TABLE 39 GLOBAL ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 138
  • TABLE 40 GLOBAL OTHERS IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 139
  • TABLE 41 GLOBAL HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 143
  • TABLE 42 GLOBAL DIRECT TENDERS IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 144
  • TABLE 43 GLOBAL RETAIL SALES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 145
  • TABLE 44 GLOBAL HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 151
  • TABLE 45 NORTH AMERICA HIGH CONTENT SCREENING MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 156
  • TABLE 46 NORTH AMERICA HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 156
  • TABLE 47 NORTH AMERICA INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 156
  • TABLE 48 NORTH AMERICA CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 157
  • TABLE 49 NORTH AMERICA HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 157
  • TABLE 50 NORTH AMERICA CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 157
  • TABLE 51 NORTH AMERICA HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 158
  • TABLE 52 NORTH AMERICA PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 158
  • TABLE 53 NORTH AMERICA TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 158
  • TABLE 54 NORTH AMERICA TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 159
  • TABLE 55 NORTH AMERICA COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 159
  • TABLE 56 NORTH AMERICA HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 160
  • TABLE 57 NORTH AMERICA OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 160
  • TABLE 58 NORTH AMERICA 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 160
  • TABLE 59 NORTH AMERICA HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 161
  • TABLE 60 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 161
  • TABLE 61 NORTH AMERICA CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 161
  • TABLE 62 NORTH AMERICA LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 162
  • TABLE 63 NORTH AMERICA ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 162
  • TABLE 64 NORTH AMERICA HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 162
  • TABLE 65 U.S. HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 163
  • TABLE 66 U.S. INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 163
  • TABLE 67 U.S. CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 163
  • TABLE 68 U.S. HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 164
  • TABLE 69 U.S. CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 164
  • TABLE 70 U.S. HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 164
  • TABLE 71 U.S. PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 165
  • TABLE 72 U.S. TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 165
  • TABLE 73 U.S. TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 165
  • TABLE 74 U.S. COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 166
  • TABLE 75 U.S. HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 166
  • TABLE 76 U.S. OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 166
  • TABLE 77 U.S. 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 167
  • TABLE 78 U.S. HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 167
  • TABLE 79 U.S. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 167
  • TABLE 80 U.S. CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 168
  • TABLE 81 U.S. LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 168
  • TABLE 82 U.S. ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 168
  • TABLE 83 U.S. HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 169
  • TABLE 84 CANADA HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 170
  • TABLE 85 CANADA INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 170
  • TABLE 86 CANADA CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 171
  • TABLE 87 CANADA HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 171
  • TABLE 88 CANADA CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 171
  • TABLE 89 CANADA HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 172
  • TABLE 90 CANADA PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 172
  • TABLE 91 CANADA TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 172
  • TABLE 92 CANADA TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 173
  • TABLE 93 CANADA COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 173
  • TABLE 94 CANADA HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 174
  • TABLE 95 CANADA OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 174
  • TABLE 96 CANADA 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 174
  • TABLE 97 CANADA HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 175
  • TABLE 98 CANADA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 175
  • TABLE 99 CANADA CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 175
  • TABLE 100 CANADA LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 176
  • TABLE 101 CANADA ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 176
  • TABLE 102 CANADA HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 176
  • TABLE 103 MEXICO HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 177
  • TABLE 104 MEXICO INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 177
  • TABLE 105 MEXICO CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 178
  • TABLE 106 MEXICO HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 178
  • TABLE 107 MEXICO CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 178
  • TABLE 108 MEXICO HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 179
  • TABLE 109 MEXICO PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 179
  • TABLE 110 MEXICO TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 179
  • TABLE 111 MEXICO TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 180
  • TABLE 112 MEXICO COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 180
  • TABLE 113 MEXICO HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 181
  • TABLE 114 MEXICO OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 181
  • TABLE 115 MEXICO PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 181
  • TABLE 116 MEXICO CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 182
  • TABLE 117 MEXICO LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 182
  • TABLE 118 MEXICO ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 182
  • TABLE 119 MEXICO HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 183
  • TABLE 120 EUROPE HIGH CONTENT SCREENING MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 188
  • TABLE 121 EUROPE HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 189
  • TABLE 122 EUROPE INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 189
  • TABLE 123 EUROPE CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 189
  • TABLE 124 EUROPE HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 190
  • TABLE 125 EUROPE CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 190
  • TABLE 126 EUROPE HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 190
  • TABLE 127 EUROPE PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 191
  • TABLE 128 EUROPE TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 191
  • TABLE 129 EUROPE TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 191
  • TABLE 130 EUROPE COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 192
  • TABLE 131 EUROPE HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 192
  • TABLE 132 EUROPE OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 192
  • TABLE 133 EUROPE 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 193
  • TABLE 134 EUROPE HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 193
  • TABLE 135 EUROPE PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 193
  • TABLE 136 EUROPE CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 194
  • TABLE 137 EUROPE LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 194
  • TABLE 138 EUROPE ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 194
  • TABLE 139 EUROPE HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 195
  • TABLE 140 GERMANY HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 196
  • TABLE 141 GERMANY INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 196
  • TABLE 142 GERMANY CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 197
  • TABLE 143 GERMANY HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 197
  • TABLE 144 GERMANY CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 197
  • TABLE 145 GERMANY HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 198
  • TABLE 146 GERMANY PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 198
  • TABLE 147 GERMANY TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 198
  • TABLE 148 GERMANY TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 199
  • TABLE 149 GERMANY COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 199
  • TABLE 150 GERMANY HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 200
  • TABLE 151 GERMANY OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 200
  • TABLE 152 GERMANY 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 200
  • TABLE 153 GERMANY HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 201
  • TABLE 154 GERMANY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 201
  • TABLE 155 GERMANY CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 201
  • TABLE 156 GERMANY LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 202
  • TABLE 157 GERMANY ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 202

LIST OF FIGURES

  • FIGURE 1 GLOBAL HIGH CONTENT SCREENING MARKET: SEGMENTATION 66
  • FIGURE 2 GLOBAL HIGH CONTENT SCREENING MARKET: DATA TRIANGULATION 69
  • FIGURE 3 GLOBAL HIGH CONTENT SCREENING MARKET: DROC ANALYSIS 70
  • FIGURE 4 GLOBAL HIGH CONTENT SCREENING MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 71
  • FIGURE 5 GLOBAL HIGH CONTENT SCREENING MARKET: COMPANY RESEARCH ANALYSIS 71
  • FIGURE 6 GLOBAL HIGH CONTENT SCREENING MARKET: INTERVIEW DEMOGRAPHICS 73
  • FIGURE 7 GLOBAL HIGH CONTENT SCREENING MARKET: DBMR MARKET POSITION GRID 74
  • FIGURE 8 GLOBAL HIGH CONTENT SCREENING MARKET: MARKET APPLICATION COVERAGE GRID 75
  • FIGURE 9 GLOBAL HIGH CONTENT SCREENING MARKET: VENDOR SHARE ANALYSIS 76
  • FIGURE 10 GLOBAL HIGH CONTENT SCREENING MARKET: SEGMENTATION 79
  • FIGURE 11 ADVANCEMENT IN IMAGING TECHNOLOGIES USED FOR HIGH-CONTENT SCREENING IS EXPECTED TO DRIVE THE GROWTH OF THE GLOBAL HIGH CONTENT SCREENING MARKET IN THE FORECAST PERIOD 80
  • FIGURE 12 THE PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL HIGH CONTENT SCREENING MARKET IN 2023 AND 2030 80
  • FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL HIGH CONTENT SCREENING MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD 81
  • FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR GLOBAL HIGH CONTENT SCREENING MARKET MANUFACTURERS IN THE FORECAST PERIOD 82
  • FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL HIGH CONTENT SCREENING MARKET 88
  • FIGURE 16 GLOBAL HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE, 2022 97
  • FIGURE 17 GLOBAL HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE, 2023-2030 (USD THOUSAND) 98
  • FIGURE 18 GLOBAL HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 98
  • FIGURE 19 GLOBAL HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE, LIFELINE CURVE 99
  • FIGURE 20 GLOBAL HIGH CONTENT SCREENING MARKET: BY APPLICATION, 2022 108
  • FIGURE 21 GLOBAL HIGH CONTENT SCREENING MARKET: BY APPLICATION, 2023-2030 (USD THOUSAND) 109
  • FIGURE 22 GLOBAL HIGH CONTENT SCREENING MARKET: BY APPLICATION, CAGR (2023-2030) 109
  • FIGURE 23 GLOBAL HIGH CONTENT SCREENING MARKET: BY APPLICATION, LIFELINE CURVE 110
  • FIGURE 24 GLOBAL HIGH CONTENT SCREENING MARKET: BY TECHNOLOGY, 2022 119
  • FIGURE 25 GLOBAL HIGH CONTENT SCREENING MARKET: BY TECHNOLOGY, 2023-2030 (USD THOUSAND) 120
  • FIGURE 26 GLOBAL HIGH CONTENT SCREENING MARKET: BY TECHNOLOGY, CAGR (2023-2030) 120
  • FIGURE 27 GLOBAL HIGH CONTENT SCREENING MARKET: BY TECHNOLOGY, LIFELINE CURVE 121
  • FIGURE 28 GLOBAL HIGH CONTENT SCREENING MARKET: BY END USER, 2022 130
  • FIGURE 29 GLOBAL HIGH CONTENT SCREENING MARKET: BY END USER, 2023-2030 (USD THOUSAND) 131
  • FIGURE 30 GLOBAL HIGH CONTENT SCREENING MARKET: BY END USER, CAGR (2023-2030) 131
  • FIGURE 31 GLOBAL HIGH CONTENT SCREENING MARKET: BY END USER, LIFELINE CURVE 132
  • FIGURE 32 GLOBAL HIGH CONTENT SCREENING MARKET: BY DISTRIBUTION CHANNEL, 2022 141
  • FIGURE 33 GLOBAL HIGH CONTENT SCREENING MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND) 142
  • FIGURE 34 GLOBAL HIGH CONTENT SCREENING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 142
  • FIGURE 35 GLOBAL HIGH CONTENT SCREENING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 143
  • FIGURE 36 GLOBAL HIGH CONTENT SCREENING MARKET: SNAPSHOT (2022) 148
  • FIGURE 37 GLOBAL HIGH CONTENT SCREENING MARKET: BY REGION (2022) 149
  • FIGURE 38 GLOBAL HIGH CONTENT SCREENING MARKET: BY REGION (2023 & 2030) 149
  • FIGURE 39 GLOBAL HIGH CONTENT SCREENING MARKET: BY REGION (2022 & 2030) 150
  • FIGURE 40 GLOBAL HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE (2023-2030) 150
  • FIGURE 41 NORTH AMERICA HIGH CONTENT SCREENING MARKET: SNAPSHOT (2022) 153
  • FIGURE 42 NORTH AMERICA HIGH CONTENT SCREENING MARKET: BY COUNTRY (2022) 154
  • FIGURE 43 NORTH AMERICA HIGH CONTENT SCREENING MARKET: BY COUNTRY (2023 & 2030) 154
  • FIGURE 44 NORTH AMERICA HIGH CONTENT SCREENING MARKET: BY COUNTRY (2022 & 2030) 155
  • FIGURE 45 NORTH AMERICA HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE (2023-2030) 155
  • FIGURE 46 EUROPE HIGH CONTENT SCREENING MARKET: SNAPSHOT (2022) 185
  • FIGURE 47 EUROPE HIGH CONTENT SCREENING MARKET: BY COUNTRY (2022) 186
  • FIGURE 48 EUROPE HIGH CONTENT SCREENING MARKET: BY COUNTRY (2023 & 2030) 186
  • FIGURE 49 EUROPE HIGH CONTENT SCREENING MARKET: BY COUNTRY (2022 & 2030) 187
  • FIGURE 50 EUROPE HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE (2023-2030) 187
  • FIGURE 51 ASIA-PACIFIC HIGH CONTENT SCREENING MARKET: SNAPSHOT (2022) 303
  • FIGURE 52 ASIA-PACIFIC HIGH CONTENT SCREENING MARKET: BY COUNTRY (2022) 304
  • FIGURE 53 ASIA-PACIFIC HIGH CONTENT SCREENING MARKET: BY COUNTRY (2023 & 2030) 304
  • FIGURE 54 ASIA-PACIFIC HIGH CONTENT SCREENING MARKET: BY COUNTRY (2022 & 2030) 305
  • FIGURE 55 ASIA-PACIFIC HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE (2023-2030) 305
  • FIGURE 56 SOUTH AMERICA HIGH CONTENT SCREENING MARKET: SNAPSHOT (2022) 407
  • FIGURE 57 SOUTH AMERICA HIGH CONTENT SCREENING MARKET: BY COUNTRY (2022) 408
  • FIGURE 58 SOUTH AMERICA HIGH CONTENT SCREENING MARKET: BY COUNTRY (2023 & 2030) 408
  • FIGURE 59 SOUTH AMERICA HIGH CONTENT SCREENING MARKET: BY COUNTRY (2022 & 2030) 409
  • FIGURE 60 SOUTH AMERICA HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE (2023-2030) 409
  • FIGURE 61 MIDDLE EAST AND AFRICA HIGH CONTENT SCREENING MARKET: SNAPSHOT (2022) 433
  • FIGURE 62 MIDDLE EAST AND AFRICA HIGH CONTENT SCREENING MARKET: BY COUNTRY (2022) 434
  • FIGURE 63 MIDDLE EAST AND AFRICA HIGH CONTENT SCREENING MARKET: BY COUNTRY (2023 & 2030) 434
  • FIGURE 64 MIDDLE EAST AND AFRICA HIGH CONTENT SCREENING MARKET: BY COUNTRY (2022 & 2030) 435
  • FIGURE 65 MIDDLE EAST AND AFRICA HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE (2023-2030) 435
  • FIGURE 66 GLOBAL HIGH CONTENT SCREENING MARKET: COMPANY SHARE 2022 (%) 507
  • FIGURE 67 NORTH AMERICA HIGH CONTENT SCREENING MARKET: COMPANY SHARE 2022 (%) 508
  • FIGURE 68 EUROPE HIGH CONTENT SCREENING MARKET: COMPANY SHARE 2022 (%) 509
  • FIGURE 69 ASIA-PACIFIC HIGH CONTENT SCREENING MARKET: COMPANY SHARE 2022 (%) 510